Header Logo

Connection

OLIVIER LICHTARGE to Cyclin-Dependent Kinase Inhibitor p21

Back to Details
This is a "connection" page, showing publications OLIVIER LICHTARGE has written about Cyclin-Dependent Kinase Inhibitor p21.
OLIVIER LICHTARGE
Connection Strength
0.030
Cyclin-Dependent Kinase Inhibitor p21
  1. Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence. Mol Cancer Ther. 2015 Feb; 14(2):608-19.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.